{"id":749149,"date":"2023-04-19T11:03:31","date_gmt":"2023-04-19T15:03:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/"},"modified":"2023-04-19T11:03:31","modified_gmt":"2023-04-19T15:03:31","slug":"precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/","title":{"rendered":"Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined"},"content":{"rendered":"

\nQ1-2023 product revenues approximately $0.76M exceeded the $0.66M combined revenue of Q3+Q4 2022
\n<\/h2>\n
\n

NEW HAVEN, Conn., April 19, 2023 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc.<\/u><\/a>(NASDAQ: PRPO)<\/u><\/a>, announces that Q1-2023 product revenues have surpassed product revenues during the two prior quarters of 2022, and exceed 50% of the entire year of 2022 product revenues of $1.4M. This equals a current annualized run rate of $3M, which is more than double the total product revenues for 2022.<\/p>\n

This represents a significant increase in revenue, consistent with the Company\u2019s previous announcements tracking the growth of the Products revenues due to new customers signed up.<\/p>\n

Please note that these revenues are preliminary, unaudited numbers; the Company expects to file its complete Q1 financials, including pathology revenues, within the deadline of May 15th<\/sup>.<\/p>\n

\u201cAs promised, the Company is executing on the conversion<\/u><\/strong> of prospects into signed customers, and delivering revenue results showing substantial growth both YoY and over the previous quarters,\u201d said Ilan Danieli, CEO. \u201cWe are making great strides on the roadmap we outlined towards the goal for this year of reaching breakeven. Every quarter with revenue growth and increased customer base means a lower cash burn going forward as we approach profitability\u201d.<\/p>\n

\n About Precipio<\/strong>\n <\/p>\n

Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide, as well as proprietary products that serve laboratories worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more information, please visit\u00a0www.precipiodx.com<\/u><\/a>.<\/p>\n

Please follow us on LinkedIn<\/u><\/a>, Twitter @PrecipioDx<\/u><\/a> and on Facebook<\/u><\/a>.<\/p>\n

\n Forward-Looking Statements<\/strong>\n <\/p>\n

This press release contains \u201cforward-looking statements\u201d within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the novel coronavirus (COVID-19) pandemic, and the related responses of the government, consumers, and the company, on our business, financial condition and results of operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise, involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, growth, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management\u2019s estimates, beliefs, assumptions and projections. Words such as \u201ccould,\u201d \u201cmay,\u201d \u201cexpects,\u201d \u201canticipates,\u201d \u201cwill,\u201d \u201ctargets,\u201d \u201cgoals,\u201d \u201cprojects,\u201d \u201cintends,\u201d \u201cplans,\u201d \u201cbelieves,\u201d \u201cseeks,\u201d \u201cestimates,\u201d \u201cpredicts,\u201d and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance, are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management\u2019s expectations, or could affect the company\u2019s ability to achieve its strategic goals, includes factors that are described in the sections entitled \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis\u201d in the company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as updated from time to time in the company\u2019s Securities and Exchange Commission filings.<\/p>\n

The company\u2019s forward-looking statements in this press release are based on management\u2019s current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this release. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.\u00a0<\/p>\n


\n
\n \n <\/div>\n

\n
Inquiries:\r\n\r\ninvestors@precipiodx.com\r\n\r\n+1-203-787-7888 Ext. 523<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"
Q1-2023 product revenues approximately $0.76M exceeded the $0.66M combined revenue of Q3+Q4 2022 NEW HAVEN, Conn., April 19, 2023 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc.(NASDAQ: PRPO), announces that Q1-2023 product revenues have surpassed product revenues during the two prior quarters of 2022, and exceed 50% of the entire year of 2022 product revenues of $1.4M. This equals a current annualized run rate of $3M, which is more than double the total product revenues for 2022. This represents a significant increase in revenue, consistent with the Company\u2019s previous announcements tracking the growth of the Products revenues due to new customers signed up. Please note that these revenues are preliminary, unaudited numbers; the Company expects to file its complete … <\/p>\n
Continue reading “Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-749149","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPrecipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Q1-2023 product revenues approximately $0.76M exceeded the $0.66M combined revenue of Q3+Q4 2022 NEW HAVEN, Conn., April 19, 2023 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc.(NASDAQ: PRPO), announces that Q1-2023 product revenues have surpassed product revenues during the two prior quarters of 2022, and exceed 50% of the entire year of 2022 product revenues of $1.4M. This equals a current annualized run rate of $3M, which is more than double the total product revenues for 2022. This represents a significant increase in revenue, consistent with the Company\u2019s previous announcements tracking the growth of the Products revenues due to new customers signed up. Please note that these revenues are preliminary, unaudited numbers; the Company expects to file its complete … Continue reading "Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-19T15:03:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTIxNiM1NTMzODgzIzIwOTYwMTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined\",\"datePublished\":\"2023-04-19T15:03:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\\\/\"},\"wordCount\":642,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMTIxNiM1NTMzODgzIzIwOTYwMTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\\\/\",\"name\":\"Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMTIxNiM1NTMzODgzIzIwOTYwMTU=\",\"datePublished\":\"2023-04-19T15:03:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMTIxNiM1NTMzODgzIzIwOTYwMTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMTIxNiM1NTMzODgzIzIwOTYwMTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/","og_locale":"en_US","og_type":"article","og_title":"Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined - Market Newsdesk","og_description":"Q1-2023 product revenues approximately $0.76M exceeded the $0.66M combined revenue of Q3+Q4 2022 NEW HAVEN, Conn., April 19, 2023 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc.(NASDAQ: PRPO), announces that Q1-2023 product revenues have surpassed product revenues during the two prior quarters of 2022, and exceed 50% of the entire year of 2022 product revenues of $1.4M. This equals a current annualized run rate of $3M, which is more than double the total product revenues for 2022. This represents a significant increase in revenue, consistent with the Company\u2019s previous announcements tracking the growth of the Products revenues due to new customers signed up. Please note that these revenues are preliminary, unaudited numbers; the Company expects to file its complete … Continue reading \"Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-19T15:03:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTIxNiM1NTMzODgzIzIwOTYwMTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined","datePublished":"2023-04-19T15:03:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/"},"wordCount":642,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTIxNiM1NTMzODgzIzIwOTYwMTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/","name":"Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTIxNiM1NTMzODgzIzIwOTYwMTU=","datePublished":"2023-04-19T15:03:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTIxNiM1NTMzODgzIzIwOTYwMTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMTIxNiM1NTMzODgzIzIwOTYwMTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-unaudited-q1-2023-product-revenues-exceed-the-two-prior-quarters-q3q4-of-2022-combined\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749149","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=749149"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749149\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=749149"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=749149"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=749149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}